Estimated Ventricular Size, Asthma Severity, and Exacerbations: The Severe Asthma Research Program III Cohort
- PMID: 31521672
- PMCID: PMC7005378
- DOI: 10.1016/j.chest.2019.08.2185
Estimated Ventricular Size, Asthma Severity, and Exacerbations: The Severe Asthma Research Program III Cohort
Abstract
Background: Relative enlargement of the pulmonary artery (PA) on chest CT imaging is associated with respiratory exacerbations in patients with COPD or cystic fibrosis. We sought to determine whether similar findings were present in patients with asthma and whether these findings were explained by differences in ventricular size.
Methods: We measured the PA and aorta diameters in 233 individuals from the Severe Asthma Research Program III cohort. We also estimated right, left, and total epicardial cardiac ventricular volume indices (eERVVI, eELVVI, and eETVVI, respectively). Associations between the cardiac and PA measures (PA-to-aorta [PA/A] ratio, eERVVI-to-eELVVI [eRV/eLV] ratio, eERVVI, eELVVI, eETVVI) and clinical measures of asthma severity were assessed by Pearson correlation, and associations with asthma severity and exacerbation rate were evaluated by multivariable linear and zero-inflated negative binomial regression.
Results: Asthma severity was associated with smaller ventricular volumes. For example, those with severe asthma had 36.1 mL/m2 smaller eETVVI than healthy control subjects (P = .003) and 14.1 mL/m2 smaller eETVVI than those with mild/moderate disease (P = .011). Smaller ventricular volumes were also associated with a higher rate of asthma exacerbations, both retrospectively and prospectively. For example, those with an eETVVI less than the median had a 57% higher rate of exacerbations during follow-up than those with eETVVI greater than the median (P = .020). Neither PA/A nor eRV/eLV was associated with asthma severity or exacerbations.
Conclusions: In patients with asthma, smaller cardiac ventricular size may be associated with more severe disease and a higher rate of asthma exacerbations.
Trial registry: ClinicalTrials.gov; No.: NCT01761630; URL: www.clinicaltrials.gov.
Keywords: CT imaging; asthma; heart.
Copyright © 2019 American College of Chest Physicians. Published by Elsevier Inc. All rights reserved.
Figures


Comment in
-
Estimated Ventricular Size: A New Predictor of Asthma Severity and Exacerbation Rate?Chest. 2020 Feb;157(2):243-244. doi: 10.1016/j.chest.2019.10.019. Chest. 2020. PMID: 32033641 No abstract available.
Similar articles
-
Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.Lancet Respir Med. 2016 Aug;4(8):636-645. doi: 10.1016/S2213-2600(16)30105-9. Epub 2016 Jun 10. Lancet Respir Med. 2016. PMID: 27298019 Free PMC article.
-
Pulmonary artery to aorta ratio is associated with cardiac structure and functional changes in mild-to-moderate COPD.Int J Chron Obstruct Pulmon Dis. 2017 May 12;12:1439-1446. doi: 10.2147/COPD.S131413. eCollection 2017. Int J Chron Obstruct Pulmon Dis. 2017. PMID: 28553096 Free PMC article.
-
Pulmonary Artery Enlargement Is Associated With Cardiac Injury During Severe Exacerbations of COPD.Chest. 2016 May;149(5):1197-204. doi: 10.1378/chest.15-1504. Epub 2016 Jan 12. Chest. 2016. PMID: 26501747 Free PMC article.
-
Pulmonary arterial enlargement and acute exacerbations of COPD.N Engl J Med. 2012 Sep 6;367(10):913-21. doi: 10.1056/NEJMoa1203830. Epub 2012 Sep 3. N Engl J Med. 2012. PMID: 22938715 Free PMC article.
-
Combined Forced Expiratory Volume in 1 Second and Forced Vital Capacity Bronchodilator Response, Exacerbations, and Mortality in Chronic Obstructive Pulmonary Disease.Ann Am Thorac Soc. 2019 Jul;16(7):826-835. doi: 10.1513/AnnalsATS.201809-601OC. Ann Am Thorac Soc. 2019. PMID: 30908927 Free PMC article.
Cited by
-
The emerging role of quantitative imaging in asthma.Br J Radiol. 2022 Apr 1;95(1132):20201133. doi: 10.1259/bjr.20201133. Epub 2020 Dec 3. Br J Radiol. 2022. PMID: 33242252 Free PMC article.
References
Publication types
MeSH terms
Associated data
Grants and funding
- R01 HL122464/HL/NHLBI NIH HHS/United States
- UL1 TR000427/TR/NCATS NIH HHS/United States
- K23 HL136905/HL/NHLBI NIH HHS/United States
- U01 HL146002/HL/NHLBI NIH HHS/United States
- R01 HL116473/HL/NHLBI NIH HHS/United States
- U10 HL109250/HL/NHLBI NIH HHS/United States
- L30 HL134158/HL/NHLBI NIH HHS/United States
- R01 HL122531/HL/NHLBI NIH HHS/United States
- UL1 TR001420/TR/NCATS NIH HHS/United States
- U10 HL109172/HL/NHLBI NIH HHS/United States
- U10 HL109257/HL/NHLBI NIH HHS/United States
- K23 HL114735/HL/NHLBI NIH HHS/United States
- T32 HL007633/HL/NHLBI NIH HHS/United States
- S10 OD018526/OD/NIH HHS/United States
- R01 HL116931/HL/NHLBI NIH HHS/United States
- K23 AI125785/AI/NIAID NIH HHS/United States
- U10 HL109164/HL/NHLBI NIH HHS/United States
- UL1 TR000448/TR/NCATS NIH HHS/United States
- UL1 TR002373/TR/NCATS NIH HHS/United States
- P30 DK054759/DK/NIDDK NIH HHS/United States
- U10 HL109086/HL/NHLBI NIH HHS/United States
- U10 HL109168/HL/NHLBI NIH HHS/United States
- K08 HL145118/HL/NHLBI NIH HHS/United States
- UL1 TR001102/TR/NCATS NIH HHS/United States
- UL1 TR002345/TR/NCATS NIH HHS/United States
- U10 HL109152/HL/NHLBI NIH HHS/United States
- U10 HL109146/HL/NHLBI NIH HHS/United States